There also was an improvement in the free/total PSA ratio of 27.
What does F/T stand for?
F/T stands for Free/Total PSA (Prostate-Specific Antigen) Ratio
This definition appears somewhat frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of F/T
We have 47 other meanings of F/T in our Acronym Attic
- Frozen Section (histology)
- Fuel Surcharge
- Full Service
- Full Sleeve (shirt)
- for show only
- For the Services of
- Facilities/Scheduling Request Form (University of South Carolina Aiken)
- Flats Tub (Canada Post)
- Force and Torque
Samples in periodicals archive:
Abstract Objective: We retrospectively evaluated the relationship between preoperative prostate specific antigen (PSA), PSA density, free/total PSA ratio and unfavorable pathological features of surgical specimen and biochemical failure in patients with clinically localized prostate cancer who have undergone radical retropubic prostatectomy.
All categories of cholesterol-lowering drugs, including statins, resulted in significant decreases in median prostate-specific antigen (PSA) levels and median free/total PSA ratios.
PSA-T concentrations had been determined earlier with the commercial Prostatus Free/Total PSA Kit (Perkin-Elmer Life Sciences).
Ratio free/total PSA (%f-PSA) in men with total PSA 0.
Thus, BPH nodules exert a powerful influence on serum PSA; in fact, the free/total PSA ratio (and the complex/total PSA ratio, an indirect measure of free PSA) is probably nothing more than an estimate of the amount of BPH contributing to serum PSA, an estimate that can be made equally well by measuring the size of the prostate, or better yet, the size of the transition zone (in which BPH arises) by transrectal ultrasound (14).
Recent studies indicate that the free/total PSA ratio in serum is lower in patients with CaP than in patients with BPH, thus enhancing the clinical usefulness of PSA testing in CaP screening programs [Scorilas et al.
The authors of the Technical Brief cited above reply: To the Editor: Our observation of a prostate-specific antigen (PSA) gap in the serum of patients with prostate carcinoma (PCa) and the assumption of the increased occurrence of minor PSA forms in serum may explain the better discrimination between PCa and benign prostatic hyperplasia (BPH) patients by the free/total PSA ratio compared with the determination of the [[alpha].